Posts by: Joana Carvalho, PhD

Joana Carvalho, PhD

Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.

May 28, 2020May 28, 2020

Bacteria Composition Changes Along the Reproductive Tract of Women with Endometriosis, Study Finds

News

Bacteria composition changes along the reproductive tract of women with endometriosis and may be used to estimate the risk a woman has of developing the disease, a study has found. ... Read more

May 21, 2020May 21, 2020

Endometriosis Study Identifies Main Contributors to Sexual Dysfunction

News

Anxiety, depression, poor sleep quality, pelvic pain, and pain during sex are all risk factors of sexual dysfunction in women with endometriosis, according to a new study. These findings highlight ... Read more

April 30, 2020April 30, 2020

Relugolix Combo Safely Eases Pelvic Pain in Women With Endometriosis, Trial Shows

News

Relugolix safely alleviates menstrual and non-menstrual pelvic pain in women with endometriosis when administered once-a-day in combination with estradiol and progestin, data from a Phase 3 trial show. “The clinically-meaningful results ... Read more

April 9, 2020April 9, 2020

Nanoparticles Containing Fluorescent Dye May Help Alleviate Endometriosis Pain, Fertility Issues, Study Says

News

Tiny particles, or nanoparticles, containing a special fluorescent dye that labels and eliminates lesions caused by endometriosis can be used to alleviate pain and fertility issues associated with the disease, ... Read more

March 26, 2020March 26, 2020

Phase 3 Trials of Linzagolix for Endometriosis on Hold Amid COVID-19 Pandemic

News

Due to the COVID-19 pandemic, ObsEva has put on hold its key Phase 3 clinical trials, confirming the safety and efficacy of linzagolix, an experimental oral therapy intended to alleviate pain ... Read more

January 28, 2020January 28, 2020

Scientists Discover Stem Cells That Can Promote Endometriosis, Endometrial Cancer, Research Shows

News

Stem cells responsible for repairing the womb following menstruation can also promote endometriosis and endometrial cancer if they become dysfunctional, researchers have found. Such malfunctioning stem cells also can reduce ... Read more

October 24, 2019October 24, 2019

Myovant Completes Patient Recruitment for Phase 3 Spirit 1 Trial of Relugolix

News

Myovant Sciences has completed patient recruitment for its ongoing Phase 3 SPIRIT 1 clinical trial assessing the safety and effectiveness of relugolix in combination with estradiol and progestin to treat ... Read more

August 20, 2019August 20, 2019

Predictive Launches PGxPLUS+ Test for Patients with Chronic Pain of Endometriosis and Other Illnesses

News

Predictive Laboratories has begun to commercialize PGxPLUS+, a test developed to assess the effect of genetic factors in the way a patient responds to pain medications, for people living with endometriosis, osteoarthritis, ... Read more

August 2, 2019August 2, 2019

Medicinal Herb Reduces Size of Lesions in Rat Model of Endometriosis

News

Treatment with the aerial parts of the stinging needle (Urtica dioica L.), a plant used in traditional medicine, reduced the size of endometrial lesions in a rat model of endometriosis, ... Read more

July 11, 2019July 11, 2019

DotLab Secures $10M to Fund Development of its Diagnostic Test for Endometriosis

News

DotLab has secured $10 million in Series A funding that will be used to drive the development of DotEndo, its proprietary noninvasive diagnostic test for endometriosis. “The revolutionary technology behind ... Read more